rs71579869
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP7
The NM_015080.4(NRXN2):c.4437C>T(p.Ala1479Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000421 in 1,568,530 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000066 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000040 ( 1 hom. )
Consequence
NRXN2
NM_015080.4 synonymous
NM_015080.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.69
Publications
1 publications found
Genes affected
NRXN2 (HGNC:8009): (neurexin 2) This gene encodes a member of the neurexin gene family. The products of these genes function as cell adhesion molecules and receptors in the vertebrate nervous system. These genes utilize two promoters. The majority of transcripts are produced from the upstream promoter and encode alpha-neurexin isoforms while a smaller number of transcripts are produced from the downstream promoter and encode beta-neuresin isoforms. The alpha-neurexins contain epidermal growth factor-like (EGF-like) sequences and laminin G domains, and have been shown to interact with neurexophilins. The beta-neurexins lack EGF-like sequences and contain fewer laminin G domains than alpha-neurexins. Alternative splicing and the use of alternative promoters may generate thousands of transcript variants (PMID: 12036300, PMID: 11944992).[provided by RefSeq, Jun 2010]
NRXN2 Gene-Disease associations (from GenCC):
- autismInheritance: AD Classification: STRONG, LIMITED Submitted by: G2P, Ambry Genetics
- neurodevelopmental disorderInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP7
Synonymous conserved (PhyloP=-1.69 with no splicing effect.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NRXN2 | NM_015080.4 | c.4437C>T | p.Ala1479Ala | synonymous_variant | Exon 23 of 23 | ENST00000265459.11 | NP_055895.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NRXN2 | ENST00000265459.11 | c.4437C>T | p.Ala1479Ala | synonymous_variant | Exon 23 of 23 | 5 | NM_015080.4 | ENSP00000265459.5 | ||
| NRXN2 | ENST00000704782.1 | c.4446C>T | p.Ala1482Ala | synonymous_variant | Exon 22 of 22 | ENSP00000516031.1 | ||||
| NRXN2 | ENST00000704781.1 | c.4262-398C>T | intron_variant | Intron 21 of 21 | ENSP00000516029.1 |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 152014Hom.: 0 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
10
AN:
152014
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000657 AC: 11AN: 167522 AF XY: 0.0000770 show subpopulations
GnomAD2 exomes
AF:
AC:
11
AN:
167522
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000395 AC: 56AN: 1416516Hom.: 1 Cov.: 34 AF XY: 0.0000414 AC XY: 29AN XY: 700418 show subpopulations
GnomAD4 exome
AF:
AC:
56
AN:
1416516
Hom.:
Cov.:
34
AF XY:
AC XY:
29
AN XY:
700418
show subpopulations
African (AFR)
AF:
AC:
1
AN:
32464
American (AMR)
AF:
AC:
7
AN:
38594
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25334
East Asian (EAS)
AF:
AC:
0
AN:
37104
South Asian (SAS)
AF:
AC:
6
AN:
81008
European-Finnish (FIN)
AF:
AC:
0
AN:
48042
Middle Eastern (MID)
AF:
AC:
5
AN:
5466
European-Non Finnish (NFE)
AF:
AC:
32
AN:
1089896
Other (OTH)
AF:
AC:
5
AN:
58608
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000658 AC: 10AN: 152014Hom.: 0 Cov.: 31 AF XY: 0.0000539 AC XY: 4AN XY: 74246 show subpopulations
GnomAD4 genome
AF:
AC:
10
AN:
152014
Hom.:
Cov.:
31
AF XY:
AC XY:
4
AN XY:
74246
show subpopulations
African (AFR)
AF:
AC:
1
AN:
41396
American (AMR)
AF:
AC:
2
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5168
South Asian (SAS)
AF:
AC:
0
AN:
4814
European-Finnish (FIN)
AF:
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
AC:
7
AN:
67954
Other (OTH)
AF:
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Sep 04, 2014
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.